Factors involved in gastroesophageal varix-related events in patients with hepatitis C virus-related compensated and decompensated cirrhosis after direct-acting antiviral therapy

被引:3
作者
Tahata, Yuki [1 ]
Hikita, Hayato [1 ]
Mochida, Satoshi [2 ]
Enomoto, Nobuyuki [3 ]
Kawada, Norifumi [4 ]
Ido, Akio [5 ]
Miki, Daiki [6 ]
Kurosaki, Masayuki [7 ]
Yoshiji, Hitoshi [8 ]
Sakamori, Ryotaro [1 ]
Kuroda, Hidekatsu [9 ]
Yatsuhashi, Hiroshi [10 ]
Yamashita, Taro [11 ]
Hiasa, Yoichi [12 ]
Kato, Naoya [13 ]
Miyaaki, Hisamitsu [14 ]
Ueno, Yoshiyuki [15 ]
Itoh, Yoshito [16 ]
Matsuura, Kentaro [17 ]
Takami, Taro [18 ]
Asahina, Yasuhiro [19 ]
Suda, Goki [20 ]
Akuta, Norio [21 ]
Tateishi, Ryosuke [22 ]
Nakamoto, Yasunari [23 ]
Kakazu, Eiji [24 ]
Terai, Shuji [25 ]
Shimizu, Masahito [26 ]
Miyazaki, Masanori [27 ]
Nozaki, Yasutoshi [28 ]
Sobue, Satoshi [29 ]
Yano, Hiroki [30 ]
Miyaki, Tomokatsu [31 ]
Moriuchi, Akihiro [32 ]
Hori, Takeshi [33 ]
Shirai, Kumiko [1 ]
Murai, Kazuhiro [1 ]
Saito, Yoshinobu [1 ]
Kodama, Takahiro [1 ]
Tatsumi, Tomohide [1 ]
Yamada, Tomomi [34 ]
Takehara, Tetsuo [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Saitama Med Univ, Dept Gastroenterol & Hepatol, Saitama, Japan
[3] Univ Yamanashi, Fac Med, Dept Internal Med 1, Yamanashi, Japan
[4] Osaka Metropolitan Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan
[5] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima, Japan
[6] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
[7] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[8] Nara Med Univ, Dept Gastroenterol, Nara, Japan
[9] Iwate Med Univ, Dept Internal Med, Div Hepatol, Yahaba, Iwate, Japan
[10] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan
[11] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan
[12] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan
[13] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[14] Nagasaki Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Hepatol, Nagasaki, Japan
[15] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata, Japan
[16] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan
[17] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Japan
[18] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan
[19] Tokyo Med & Dent Univ, Dept Liver Dis Control, Dept Gastroenterol & Hepatol, Tokyo, Japan
[20] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
[21] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
[22] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[23] Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan
[24] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan
[25] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan
[26] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu, Japan
[27] Osaka Police Hosp, Dept Gastroenterol, Osaka, Japan
[28] Kansai Rosai Hosp, Dept Pathol, Amagasaki, Hyogo, Japan
[29] Kasugai Municipal Hosp, Dept Gastroenterol, Kasugai, Aichi, Japan
[30] Oshima Hosp, Dept Gastroenterol, Kagoshima, Japan
[31] Toyokawa City Hosp, Dept Gastroenterol, Toyokawa, Japan
[32] Natl Hosp Org, Dept Gastroenterol, Kagoshima Med Ctr, Kagoshima, Japan
[33] Kagoshima City Hosp, Dept Gastroenterol, Kagoshima, Japan
[34] Osaka Univ Hosp, Dept Med Innovat, Suita, Osaka, Japan
关键词
DAA; esophagogastric varix; HCV; sustained virologic response; varix aggravation; varix rupture; CLINICAL-PRACTICE GUIDELINES; GENOTYPE; NATURAL-HISTORY; SOFOSBUVIR; LEDIPASVIR;
D O I
10.1111/hepr.14131
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe incidence of and factors involved in gastroesophageal varix-related events in hepatitis C virus-related cirrhosis patients, including decompensated cirrhosis, after direct-acting antiviral therapy are unclear. MethodsWe conducted a multicenter study using prospective data from 478 hepatitis C virus-related cirrhosis patients treated with direct-acting antiviral therapy from February 2019 to December 2021 at 33 Japanese hospitals. Gastroesophageal varices were classified as F1 (small-caliber), F2 (moderately enlarged), or F3 (markedly enlarged) according to the Japanese criteria. Patients without varix or with F1 without red color signs were defined as low-risk varix, and patients with >= F2 or red color signs or a history of rupture were defined as high-risk varix. Varix-related events were defined as prophylactic treatment or rupture of gastroesophageal varix. ResultsThe median age was 70 years, 43% of patients had decompensated cirrhosis, and 16% had high-risk varices (13% in compensated and 33% in decompensated, p < 0.001). Sustained virologic response rates were 94.9% for compensated cirrhosis and 91.3% for decompensated cirrhosis (p = 0.120). Across 35.7 months, 25 patients received prophylactic treatment, and four experienced varix rupture. The 3-year incidence rate of varix-related events was 6.2% (3.5% in compensated and 9.9% in decompensated, p = 0.001). In the multivariate analysis, high-risk varix (p < 0.001), high baseline gamma-glutamyl transpeptidase levels (p < 0.001), and virologic failure (p = 0.004) were significantly involved in varix-related events. ConclusionsThe cumulative incidence rate of varix-related events was significantly higher in decompensated cirrhosis than in compensated cirrhosis. Baseline varix status, baseline gamma-glutamyl transpeptidase levels, and virologic response were related to varix-related events after direct-acting antiviral therapy.
引用
收藏
页码:319 / 332
页数:14
相关论文
共 35 条
[1]   Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Zeuzem, Stefan ;
Kwo, Paul ;
Chojkier, Mario ;
Gitlin, Norman ;
Puoti, Massimo ;
Romero-Gomez, Manuel ;
Zarski, Jean-Pierre ;
Agarwal, Kosh ;
Buggisch, Peter ;
Foster, Graham R. ;
Braeu, Norbert ;
Buti, Maria ;
Jacobson, Ira M. ;
Subramanian, G. Mani ;
Ding, Xiao ;
Mo, Hongmei ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Mangia, Alessandra ;
Marcellin, Patrick .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) :1889-1898
[2]   Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Reddy, K. Rajender ;
Nelson, David R. ;
Lawitz, Eric ;
Gordon, Stuart C. ;
Schiff, Eugene ;
Nahass, Ronald ;
Ghalib, Reem ;
Gitlin, Norman ;
Herring, Robert ;
Lalezari, Jacob ;
Younes, Ziad H. ;
Pockros, Paul J. ;
Di Bisceglie, Adrian M. ;
Arora, Sanjeev ;
Subramanian, G. Mani ;
Zhu, Yanni ;
Dvory-Sobol, Hadas ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
Kwo, Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) :1483-1493
[3]   Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis [J].
Atsukawa, Masanori ;
Tsubota, Akihito ;
Kondo, Chisa ;
Toyoda, Hidenori ;
Nakamuta, Makoto ;
Takaguchi, Koichi ;
Watanabe, Tsunamasa ;
Hiraoka, Atsushi ;
Uojima, Haruki ;
Ishikawa, Toru ;
Iwasa, Motoh ;
Tada, Toshifumi ;
Nozaki, Akito ;
Chuma, Makoto ;
Fukunishi, Shinya ;
Asano, Toru ;
Ogawa, Chikara ;
Abe, Hiroshi ;
Kato, Keizo ;
Hotta, Naoki ;
Shima, Toshihide ;
Matsuura, Kentaro ;
Mikami, Shigeru ;
Tachi, Yoshihiko ;
Fujioka, Shinichi ;
Okubo, Hironao ;
Shimada, Noritomo ;
Tani, Joji ;
Morishita, Asahiro ;
Hidaka, Isao ;
Moriya, Akio ;
Tsuji, Kunihiko ;
Akahane, Takehiro ;
Okubo, Tomomi ;
Arai, Taeang ;
Kitamura, Michika ;
Morita, Kiyoshi ;
Kawata, Kazuhito ;
Tanaka, Yasuhito ;
Kumada, Takashi ;
Iwakiri, Katsuhiko .
HEPATOLOGY RESEARCH, 2022, 52 (03) :235-246
[4]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[5]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[8]   EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [J].
Angeli P. ;
Bernardi M. ;
Villanueva C. ;
Francoz C. ;
Mookerjee R.P. ;
Trebicka J. ;
Krag A. ;
Laleman W. ;
Gines P. .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :406-460
[9]   Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial [J].
Forns, Xavier ;
Lee, Samuel S. ;
Valdes, Joaquin ;
Lens, Sabela ;
Ghalib, Reem ;
Aguilar, Humberto ;
Felizarta, Franco ;
Hassanein, Tarek ;
Hinrichsen, Holger ;
Rincon, Diego ;
Morillas, Rosa ;
Zeuzem, Stefan ;
Horsmans, Yves ;
Nelson, David R. ;
Yu, Yao ;
Krishnan, Preethi ;
Lin, Chih-Wei ;
Kort, Jens J. ;
Mensa, Federico J. .
LANCET INFECTIOUS DISEASES, 2017, 17 (10) :1062-1068
[10]   Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support [J].
Harris, Paul A. ;
Taylor, Robert ;
Thielke, Robert ;
Payne, Jonathon ;
Gonzalez, Nathaniel ;
Conde, Jose G. .
JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) :377-381